Zhenya Zhang

Shijiazhuang, 050011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Short-Course Radiotherapy-Based Total Neoadjuvant Therapy plus Tislelizumab for Locally Advanced Rectal Cancer (Neo-STAR): Early Outcomes of a Randomized Phase II Trial.

Short-Course Radiotherapy-Based Total Neoadjuvant Therapy plus Tislelizumab for Locally Advanced Rectal Cancer (Neo-STAR): Early Outcomes of a Randomized Phase II Trial.

Journal: Cancer communications (London, England)

Published: December 17, 2025

Using an indocyanine green fluorescent imaging technique for laparoscopic rectal cancer surgery: a case report.

Using an indocyanine green fluorescent imaging technique for laparoscopic rectal cancer surgery: a case report.

Journal: Journal of gastrointestinal oncology

Published: March 26, 2025

CapeOX Versus Capecitabine in Neoadjuvant Chemoradiation for High-Risk Locally Advanced Rectal Cancer: Long-Term Results From the MONT-R Randomized Controlled Trial.

CapeOX Versus Capecitabine in Neoadjuvant Chemoradiation for High-Risk Locally Advanced Rectal Cancer: Long-Term Results From the MONT-R Randomized Controlled Trial.

Journal: International journal of radiation oncology, biology, physics

Published: March 05, 2025

Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum.

Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum.

Journal: International journal of biological sciences

Published: July 07, 2023

SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression.

SHP-2-induced M2 polarization of tumor associated macrophages via IL-4 regulate colorectal cancer progression.

Journal: Frontiers in oncology

Published: August 25, 2022

Current status of total neoadjuvant therapy for locally advanced rectal cancer.

Current status of total neoadjuvant therapy for locally advanced rectal cancer.

Journal: Asia-Pacific journal of clinical oncology

Published: June 29, 2021

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL).

Journal: Disease markers

Published: April 11, 2021

CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1.

CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1.

Journal: International journal of biological sciences

Published: September 24, 2020

DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.

DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.

Journal: Carcinogenesis

Published: April 21, 2020

Investigation of Inhibition Effect of Gossypol-Acetic Acid on Gastric Cancer Cells Based on a Network Pharmacology Approach and Experimental Validation.

Investigation of Inhibition Effect of Gossypol-Acetic Acid on Gastric Cancer Cells Based on a Network Pharmacology Approach and Experimental Validation.

Journal: Drug design, development and therapy

Published: April 02, 2020

Demethylzeylasteral inhibits cell proliferation and enhances cell chemosensitivity to 5-fluorouracil in Colorectal Cancer cells.

Demethylzeylasteral inhibits cell proliferation and enhances cell chemosensitivity to 5-fluorouracil in Colorectal Cancer cells.

Journal: Journal of Cancer

Published: January 30, 2020

miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.

miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.

Journal: OncoTargets and therapy

Published: April 10, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026